tor. The MERS-CoV S protein is a type I membrane glycoprotein, assembled as trimers that constitute the typical crown-like peplomers on the surface of the enveloped coronavirus. Functionally, two regions, S1 and S2, can be defined in the S protein, which are involved in binding and fusion with host cells, respectively. Recent studies have mapped the receptor-binding domain (RBD) to a ~231-amino acid long region within the S1 region of MERS-CoV [3] .
MERS-CoV uses a cell surface amino peptidase, dipeptidyl peptidase 4 (DPP4), also known as CD26, as a functional receptor [4] . The multifunctional DPP4 -highly conserved among mammals -plays a major role in glucose metabolism by its degradation of incretins. It has been further implicated in T-cell activation, chemotaxis modulation, cell adhesion, and apoptosis [5] . In humans, it is primarily expressed on the epithelial cells in the lungs, kidney, small intestine, liver and prostate, and on activated leukocytes, while it also occurs in a soluble form in the circulation [4, 5] .
The spike-receptor binding interface can be seen as a lock-and-key interaction where minor mutations within the interacting domain of the S protein or the receptor can abrogate infection, placing a barrier for cross-species transmission. Zoonotic potential of coronaviruses has been attributed to the adaptability of the S protein to human receptor orthologs. Intriguingly, the MERS-CoV S protein seems promiscuous in binding to orthologous receptors. Whereas coronaviruses generally tend to have a narrow host tropism, MERS-CoV can infect cells of a wide variety of species, at least in vitro [4, 6] . The broad cell species tropism suggests that MERS-CoV has acquired facile cross-species transmissibility by binding to an evolutionarily conserved receptor.
Just four months after the discovery of the receptor, two Chinese research teams have now independently described the MERS-CoV spike-receptor interface. The study by Wang et al. [7] recently published in Cell Research, and a recent study by Lu et al. [8] published in Nature, both reveal the crystal structure of the RBD of the MERS-CoV S protein bound to its receptor, human DPP4. DPP4, of which the structure was published before [9] , consists of an N-terminal eight-bladed β-propeller domain and a C-terminal α/β-hydrolase domain. The RBD of the MERS-CoV S protein contains two subdomains: a conserved core subdomain and a receptor-binding subdomain, with the latter contacting blades 4 and 5 of the DPP4 β-propeller domain. Structural comparison with the RBD of the related betacoronavirus SARS-CoV (using the ACE2 peptidase as a receptor) reveals a conserved core domain and highly variable -both in length and in residues -receptor-binding region, explaining the differential receptor usage.
Both teams have scrutinized the RBD-receptor interface and identified critical residues within the interacting domain of the S protein or receptor, which allow MERS-CoV to bind to its receptor. Structural analysis and mutational analysis have identified several key residues in the RBD of the S protein shown to be critical for DPP4 binding and viral entry. This information is crucial to understand the adaptation of MERS-CoV to humans. Studies with npg SARS-CoV isolated from humans and civet cats (which function as the intermediate host) revealed 2 amino acids in the RBD that caused an > 1 000-fold difference in binding affinity to human receptor ACE2 [10] . Analysis of the MERS-CoV RBD sequences of the isolates characterized thus far shows no sequence variation except that 2 virus samples isolated from patients in the UK (GenBank: KC667074 and KC164505) had a leucine-to-phenylalanine substitution at position 506 of the S protein (L506F). As shown by Wang et al. [7] , residue L506 contacts DPP4 and its substitution to alanine reduced MERS-CoV S-mediated infectivity by over 50%.
With the structure available, the promiscuous binding of MERS-CoV to DPP4 orthologs can now be analyzed at the molecular level. Relevant to functional usage of orthologous receptors by MERS-CoV is the degree of conservation of the amino acid residues in DPP4 that were identified to contact the viral RBD [7, 8] . DPP4 sequence comparison reveals that mammalian DPP4 orthologs (e.g., of macaque, horse, rabbit and pig) have no or little variation for residues contacting MERS-CoV RBD in human DPP4 ( Table 1 ). The level of identity of the RBD-contacting residues in human DPP4 and DPP4 orthologs is generally lower than the homology between full-size DPP4 proteins. Notably, the DPP4 proteins of ferret and pig have an overall sequence-identity of 88% relative to human DPP4, but the identity of the RBD-contacting residues differs substantially, being 91% for pig DPP4 and only 45% for ferret DPP4 (Table  1) . Consistently, MERS-CoV can infect porcine cells, but cannot use the ferret DPP4 as a functional receptor [6, unpublished results from BLH]. The conservation degree of RBD-contacting residues in DPP4 orthologs has predictive value for functional receptor usage and may hence help to track the animal source for MERS-CoV. Mutational analysis of the RBD-contacting residues in DPP4 in combination with biochemical and functional assays is needed to better understand the critical molecular determinants for the unusual broad cell species tropism of MERS-CoV.
In conclusion, knowing the molecular details of the coronavirus-receptor interface will be highly instrumental in predicting interactions between MERSCoV and orthologous receptors and mutation-driven host range expansion, and may help to identify susceptible host species and hence the host reservoir(s) for MERS-CoV. In addition, the structural information of the interface between the S protein and the receptor may provide novel strategies for developing effective antibodies or drugs that target the spike-receptor interface.
Berend Jan Bosch Critical residues in DPP4, which contact the MERS-CoV RBD, identified by Wang et al. [7] and Lu et al. [8] . Position (human DPP4 numbering) and single-letter identity of RBD-contacting residues are indicated; 2 % identity of RBD-contacting residues in relative to those in human DPP4; 3 unpublished results from BLH. Table 1 Conservation of DPP4 residues that contact the RBD of MERS-CoV.
